The Leaflex™ Standalone Study Protocol

NATerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

November 20, 2023

Study Completion Date

August 14, 2024

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Leaflex™ Performer

A transfemoral catheter designed to treat calcific aortic stenosis by scoring the calcification in the aortic valve leaflets.

Trial Locations (1)

Unknown

Gottsegen Gyorgy Hungarian Institute of Cardiology, Budapest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pi-cardia

INDUSTRY

NCT04649099 - The Leaflex™ Standalone Study Protocol | Biotech Hunter | Biotech Hunter